Kick-off of the next phase of the EU-funded Central Asia Drug Action Programme (CADAP) in Tashkent (06/07/2010)

TASHKENT, Uzbekistan, 5 July 2010 – Today, a high-level representatives of the responsible governmental authorities for drug control, prevention and treatment from Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan, a delegation of the European Union, a representative of the German Ministry of Health, and members of the European consortium charged with the implementation of CADAP will officially launch the next 3-year programme phase.

Programme activities are aimed to help reduce:

  • Drug trafficking
  • Drug consumption
  • Drug-related harm (e.g. HIV infections)
  • Costs for the national health systems

CADAP consists of three components: DAMOS (enhancement of the knowledge of the drug situation in the country), TREAT (support to the introduction of modern drug addiction treatment) and MEDISSA (prevention and awareness raising).

The overall objective of CADAP is to facilitate the gradual adoption of EU and international good practices on drug policies and to contribute to the reduction of drug-related problems in the five Central Asian republics.

The programme will be implemented by a European consortium of institutions from the Czech Republic, Germany and Poland, led by the German Development Organisation GTZ.

Media representatives are invited to a press conference on the occasion of the project's official launch on Monday, 5 July 2010, 11.00 a.m., at the Dedeman Hotel, Amir Temur Str. C4, Nr. 7/8, Tashkent.

For accreditation please call Kamal Dusmetov (Programme's National Coordinator), at GTZ Office, tel.: +998 71 140 04 89/90 or mobile + 998 93 184 01 70

For further information please visit or contact:

  • Dr. Ingo Ilja Michels , CADAP Project Leader, GTZ Regional Office Bishkek, Kyrgyzstan: tel.: +996 312 906741,;
  • Xeniya Udod , the EU Delegation to Kazakhstan Press and Information Assistant, tel.: +7-(7172) 97-11-49,